Stabilized amorphous forms of imatinib mesylate

Details Stabilized amorphous forms of imatinib mesylate Stabilized amorphous forms of imatinib mesylate

A - Human Necessities

61

K

A61K 31/506 (2006.01) A61K 9/16 (2006.01) A61P 35/02 (2006.01)

Patent

CA 2687741

The invention relates to the stabilized amorphous form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-(pyridin-3-yl)-pyrimidin-2-ylamino)-phenyl]-benzamide, pharmaceutical compositions such as capsules or tablets containing this form, the use of such form in diagnostic methods or, preferably, for the therapeutic treatment of warm-blooded animals, especially humans, and the use of formulation principles stabilizing the amorphous form of Imatinib mesylate as an intermediate for the preparation of pharmaceutical compositions.

La présente invention concerne la forme amorphe stabilisée du sel d'addition de l'acide méthane sulfonique, le 4-(4-méthylpipérazin-1-ylméthyl)-N-[4-méthyl-3-(4-(pyridin-3-yl)-pyrimidin-2-ylamino)-phényl]-benzamide, des compositions pharmaceutiques telles que des capsules ou des comprimés contenant cette forme, l'utilisation d'une telle forme dans des procédés de diagnostic ou, de préférence, pour le traitement thérapeutique d'animaux à sang chaud, spécialement des êtres humains, et l'utilisation de principes de formulation stabilisant la forme amorphe du mésylate d'imatinib en tant qu'intermédiaire pour la préparation de compositions pharmaceutiques.

Affiliated with

Also associated with

Rating

Stabilized amorphous forms of imatinib mesylate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stabilized amorphous forms of imatinib mesylate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized amorphous forms of imatinib mesylate will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1832240